Objectives A characteristic of chronic obstructive pulmonary disease is mucus hypersecretion. In this proof-of-concept study, we aimed to characterize airway mucus using a quantitative ultrashort echo time (UTE) magnetic resonance imaging (MRI) sequence in a controlled in vitro synthetic mucus model to establish a technical foundation for future in vivo studies. Materials and methods UTE double-echo steady-state (UTE-DESS) was performed to acquire the signal from free induction decay-like signal and spin/stimulated echo-like signal echoes; quantitative MRI parameters (T1, T2, and diffusivity) were estimated. Synthetic mucus phantoms were prepared using mucin (0.20%, 0.50%, and 1.0%) mixed with xanthan gum (0.10%, 0.25%, and 0.50%) to replicate the viscoelastic properties of human laryngeal mucus, and samples were embedded in 1% agar for imaging. Results The mucus phantoms with varying concentrations of mucin and xanthan exhibited visual differences in color and opacity. Estimated T1 values were 2.23 ± 0.16, 2.37 ± 0.20, and 2.09 ± 0.18 s (mean ± standard deviation) for the three tubes with relative mucus concentrations of 1, 2.5, and 5, respectively. Corresponding T2 values were 806.6 ± 105.6, 687.4 ± 78.0, and 475.0 ± 41.3 ms, while diffusivity values were 2.36 ± 0.14, 2.31 ± 0.18, and 2.33 ± 0.18 µm 2 /ms for the three tubes. Only the T2 relaxation times showed a significant linear correlation with mucus concentration ( r = -0.9998, p = 0.0112). Conclusion UTE-DESS MRI could be feasible for characterizing airway mucus. T2 relaxation time showed a strong inverse correlation with increasing mucus concentration, indicating its sensitivity to mucus content. Key Points Question Can a novel quantitative ultrashort echo time MRI sequence noninvasively characterize airway mucus properties and overcome conventional lung imaging limitations in muco-obstructive diseases? Findings In this controlled in vitro model, UTE-DESS MRI mapping demonstrated that T2 relaxation times alone showed a strong inverse correlation with increasing mucus concentrations. Relevance statement This exploratory proof-of-concept establishes a technical foundation for radiation-free, noninvasive T2 mapping to monitor and phenotype chronic obstructive pulmonary disease and other mucoobstructive lung diseases in future in vivo studies.
No takes yet. Share an insight, caveat, or question.
Sedaghat et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: